Table 3 Association of medication combination prescribed in correlation with the HbA1c levels.
Medications combinations | HbA1c % | |
|---|---|---|
Number (%) of patients corresponding to HbA1c value | Mean (95% CI) | |
Metformin monotherapy | 50.6 (13.7) | 6.28 (6.26, 6.29) |
Sulphonylureas monotherapy | 21.0 (5.7) | 6.86 (6.80, 6.92) |
Metformin plus sulphonylureas dual therapy | 48.3 (13.1) | 6.73 (6.70, 6.76) |
Sulphonylureas plus metformin dual therapy | 53.1 (14.4) | 7.60 (7.54, 7.67) |
Metformin to DPP-4 inhibitor dual therapy | 95.9 (26) | 7.87 (7.81, 7.92) |
Metformin to sulphonylureas to SGLT-2 triple therapy | 26.9 (7.3) | 8.79 (8.73, 8.85) |
Metformin to DPP-4 inhibitors to insulin triple therapy | 67.5 (18.3) | 8.38 (8.19, 8.58) |
Metformin to SGLT-2 to GLP-1 agonist triple therapy | 5.5 (1.5) | 10.33 (10.09, 10.36) |
